Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Current Assets (2016 - 2026)

Nutex Health (NUTX) has disclosed Current Assets for 17 consecutive years, with $579.6 million as the latest value for Q1 2026.

  • For Q1 2026, Current Assets rose 44.36% year-over-year to $579.6 million; the TTM value through Mar 2026 reached $579.6 million, up 44.36%, while the annual FY2025 figure was $538.8 million, 84.22% up from the prior year.
  • Current Assets hit $579.6 million in Q1 2026 for Nutex Health, up from $538.8 million in the prior quarter.
  • Across five years, Current Assets topped out at $592.7 million in Q3 2025 and bottomed at $15.0 million in Q1 2022.
  • Average Current Assets over 5 years is $231.9 million, with a median of $113.9 million recorded in 2024.
  • On a YoY basis, Current Assets climbed as much as 2566.33% in 2022 and fell as far as 40.34% in 2022.
  • Nutex Health's Current Assets stood at $98.0 million in 2022, then decreased by 7.27% to $90.8 million in 2023, then surged by 221.94% to $292.5 million in 2024, then surged by 84.22% to $538.8 million in 2025, then grew by 7.58% to $579.6 million in 2026.
  • According to Business Quant data, Current Assets over the past three periods came in at $579.6 million, $538.8 million, and $592.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.